Kolonin et al. [76] used a peptide (KGGRAKD) with the capacity to bind specifically to prohibitin on the endothelial cell surface in white adipose tissue vessels, aiming to develop therapies for the treatment of obesity. This evidence concerns the gene PHB1 and obesity due to melanocortin 4 receptor deficiency.